|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
and PPAR
2 in denervated muscle
1 Department of Biochemical Sciences, National Institute of Fitness and Sports, 1 Shiromizu, Kanoya, Kagoshima 891-2393, Japan
| Abstract |
|---|
|
|
|---|
(C/EBP
) and peroxisome proliferator-activated receptor
2 (PPAR
2), which play an important role in the regulation of adipocyte differentiation, was assessed by immunohistochemistry. The mRNA levels were analysed using a real-time polymerase chain reaction. After muscle denervation, most muscle fibres atrophied pathologically, and lipid accumulation was observed in the superficial region of the gastrocnemius muscle, suggesting that fatty degeneration occurs in this model. Both C/EBP
and PPAR
2 proteins were observed in the interstitial space of denervated muscle but detected in small amounts in normal muscle. The expression levels of C/EBP
and PPAR
2 were significantly upregulated 30 days after muscle denervation. The expression levels of fatty acid binding protein 4 (FABP4), which reflects fatty acid metabolism, were decreased slightly at 5 and 10 days and then returned to control levels 30 days after muscle denervation. These findings suggest that muscle denervation-induced fatty degeneration may be mediated through C/EBP
and PPAR
2.
(Received 15 February 2006;
accepted after revision 7 April 2006; first published online 21 April 2006)
Corresponding author A. Wagatsuma: Department of Biochemical Sciences, National Institute of Fitness and Sports, 1 Shiromizu, Kanoya, Kagoshima 891-2393, Japan. Email: waga{at}nifs-k.ac.jp
| Introduction |
|---|
|
|
|---|
B kinase ß/NF
B (Cai et al. 2004). It has been demonstrated that muscle denervation upregulates several genes, including leptin, lipoprotein lipase and glycerol 3-phosphate dehydrogenase, associated with adipose tissue (Dulor et al. 1998), suggesting that muscle denervation activates the adipogenic potential in skeletal muscle. Although the exact mechanism(s) initiating fatty degeneration in these pathologies remains to be elucidated (Kawaguchi et al. 2002), specific adipogenic transcriptional factors have been implicated.
In vitro models of adipogenesis have revealed that the differentiation programme appears to be distinctly controlled through the co-ordinated regulation of transcription factors, including members of the CCAAT/enhancer-binding proteins (C/EBP) and peroxisome proliferator-activated receptor (PPAR) families (Cowherd et al. 1999). The family of C/EBP, including C/EBP
, ß and
, has been implicated in the induction of adipocyte differentiation (Mandrup & Lane, 1997). C/EBPß and C/EBP
induce the expression of C/EBP
and PPAR
(Rosen, 2005), while C/EBP
binds and transactivates the promoters of several adipocyte genes (Gregoire et al. 1998). The gene encoding PPAR
gives rise to two isoforms, PPAR
1 and PPAR
2 (Zhu et al. 1995). PPAR
2 appears to be more adipose specific than PPAR
1 (Vidal-Puig et al. 1996) and mediates gene expression related to fatty acid metabolism (Morrison & Farmer, 1999). Therefore, C/EBP
and PPAR
2 are critical transcriptional factors in adipocyte differentiation (Rosen et al. 2002). To our knowledge, their pattern of expression is not fully characterized in denervated muscle. Therefore, we hypothesized that the expression of PPAR
2 and C/EBP
would be modulated in response to decreased neuromuscular activity, induced by muscle denervation, leading to fatty degeneration.
To test this hypothesis, this sudy was designed to characterize the expression pattern of genes encoding transcriptional factors that regulate adipogenesis and the terminal differentiation marker of adipocytes in denervated muscle. Here, it is demonstrated that the expression levels of C/EBP
and PPAR
2 were upregulated concomitant with lipid accumulation in denervated muscle. This finding suggests that muscle denervation-induced fatty degeneration may be mediated through C/EBP
and PPAR
2.
| Methods |
|---|
|
|
|---|
Female 7-week-old CD1 mice (CLEA, Tokyo, Japan) were used in the present study. The mice were randomly assigned to two groups, the first group (n = 36) had the gastrocnemius muscle denervated, while the second group (n = 36) was not denervated and served as a control group. The mice were housed in the animal care facility under a 12 h light12 h dark cycle at room temperature (23 ± 2°C) and 55 ± 5% humidity. The mice were maintained on a diet of CE-2 rodent chow (CLEA) and given water ad libitum. All procedures in the animal experiments were performed in accordance with the guidelines presented in the Guiding Principles for the Care and Use of Animals in the Field of Physiological Sciences, published by the Physiological Society of Japan. This study was also approved by the Animal Committee of the National Institute of Fitness and Sports, Japan.
A surgical level of anaesthesia was induced by an intraperitoneal injection of sodium pentobarbitone (30 mg kg1). All surgical procedures were performed under aseptic conditions. The right sciatic nerve was isolated mid-thigh and transected 58 mm proximal to the trifurcation. The mice were killed by cervical dislocation. Gastrocnemius muscles (superficial portion) were harvested 30 days after surgery and immediately stored for histochemical and biochemical analysis.
Histochemistry and immunohistochemistry
The gastrocnemius muscle was dissected from mice and frozen in liquid nitrogen-cooled isopentane. Transverse sections (810 µm thickness) were cut using a cryostat at 20°C and thawed on 3-amino propylethoxysilane-coated slides. Lipid accumulation in muscle tissue was assessed by Oil Red O staining (Koopman et al. 2001). Briefly, the sections were fixed with 3.7% formaldehyde for 60 min and rinsed with deionized water. The sections were incubated with Oil Red O solution for 30 min and rinsed with deionized water. The nuclei were counterstained with Haematoxylin, and the sections were mounted with 10% glycerol in phosphate-buffered saline (PBS). Morphometric measurements were made using light microscopy and image collection with a CCD camera. Fibre cross-sectional area (FCSA) and lipid accumulation area were measured in selected fields (size of analysed field, 310 µm x 410 µm) in the superficial region of the gastrocnemius muscle. Fibre cross-sectional area was measured in at least 100 muscle fibres per sample. Lipid accumulation area was measured in two-to-three analysed fields per sample and expressed as the area per millimetre sqared of muscle section.
For immunohistochemical analysis, the sections were fixed with cold acetone (20°C) for 10 min and then washed with 0.1 M PBS. To quench endogenous peroxidase activity, the sections were incubated with a solution of methanol containing 1% H2O2 for 60 min. The sections were washed with 0.1 M PBS, blocked with 0.1 M PBS containing 1% bovine serum albumin and 0.1% Triton X-100, and then incubated overnight at 4°C with rabbit anti-C/EBP
antibody (1:50; Santa Cruz Biotechnology, Santa Cruz, CA, USA) and rabbit anti-PPAR
2 (1:50; Alexis Biochemicals, San Diego, CA, USA) in 0.1 M PBS containing 1% bovine serum albumin and 0.1% Triton X-100. The sections were incubated with horseradish peroxidase-conjugated secondary antibody (1:500; Molecular Probes, Eugene OR, USA) in 0.1 M PBS containing 1% bovine serum albumin and 0.1% Triton X-100 for 30 min at room temperature. To detect immunoreactive protein, the sections were incubated with 0.1 M PBS containing 0.05% 3-diaminobenzidine and 0.01% H2O2 for 10 min at room temperature.
RNA extraction and cDNA synthesis
The gastrocnemius muscles were carefully harvested, and the tissue was then transferred to glass homogenizers on ice, and 1 ml TRI reagent (Molecular Research Center, Cincinnati OH, USA) was added per 1020 mg tissue. RNA integrity was confirmed by denaturing agarose gel electrophoresis, and the concentration was quantified by measuring the optical density (OD) at 260 nm. All samples had an optical density ratio (OD260/OD280) of at least 1.9. The DNase-treated total RNA (1 µg) was then converted to cDNA using a First-strand cDNA synthesis system for quantitative real-time polymerase chain reaction (Marligen Biosciences, Ijamsville, MD, USA). The cDNA samples were aliquoted and stored at 80°C.
Real-time polymerase chain reaction (RT-PCR) analysis
Real-time PCR was performed using an OpticonTM DNA Engine (MJ Research, Waltham MA, USA) according to the manufacturer's instructions. Amplification was carried out using SYBR Premix Ex TaqTM (TaKaRa Bio, Shiga, Japan). All primers used in this study were obtained from Espec Oligo Service (Ibaraki, Japan). The reactions employed primers for MyoD, myogenin (Warren et al. 2002), CCAAT/enhancer binding protein (C/EBP
), peroxisome proliferator-activated receptor
2 (PPAR
2; Tanabe et al. 2004), fatty acid binding protein 4 (FABP4, previously known as aP2; Taylor-Jones et al. 2002), and ß-actin (Real Time PCR Primer and Probe Database; http://medgen.ugent.be/rtprimerdb/). For each set of primers, PCR thermal cycle conditions were optimized to achieve a single ethidium bromide-stained band following electrophoresis on a 2% agarose gel. Differences in gene expression were calculated relative to the expression of ß-actin and compared to a standard curve. ß-Actin was confirmed to be appropriate for normalizing the signal by comparing the differences in raw threshold cycle values (the number of amplification cycles at which the signal is detected above the background and is in the exponential phase). A standard curve was constructed from serially diluted cDNA from gastrocnemius muscle. Each sample was normalized to its ß-actin content. The final results were expressed as a relative fold-change compared to control animals.
Statistical analysis
Data are expressed as means ± S.E.M. The data were compared using unpaired Student's t test. The real-time PCR data were compared using one-way analysis of variance (ANOVA) with Fisher's least significant difference (LSD) test. A 0.05 level of probability was used as the criterion for statistical significance.
| Results |
|---|
|
|
|---|
and PPAR
2, we performed immunohistochemical analysis in normal and denervated muscles. Both C/EBP
and PPAR
2 proteins were observed in the interstitial space of denervated muscle but also detected in small amounts in normal muscle (Fig. 4).
|
|
|
|
, PPAR
2 and FABP4 mRNA transcripts were readily detected in control and denervated muscles. As shown in Fig. 5, the expression levels of MyoD and myogenin were significantly increased in the denervated muscle relative to control muscle. The expression levels of C/EBP
and PPAR
2 were significantly upregulated 30 days after muscle denervation. The expression levels of fatty acid binding protein 4 (FABP4) was slightly reduced at 5 and 10 days and then returned to control levels 30 days after muscle denervation.
|
| Discussion |
|---|
|
|
|---|
and PPAR
(Ross et al. 2000). Therefore, Wnt10b may possibly regulate adipogenic potential in satellite cells of denervated muscle.
We observed both C/EBP
and PPAR
2 proteins in the interstitial space of denervated muscle, suggesting that most of the cells which activate adipogenic potential, might be derived from preadipocytes and mesenchymal progenitors. This possibility may be partly supported by the observation that the CD34-positive and CD45-negative cells in the interstitial space of skeletal muscle have potential to differentiate into adipocytes cells in vitro (Tamaki et al. 2002). The CD34-positive and CD45-negative cell showed oil droplet-like staining typical of fat cells and was distinct from satellite cells. However, it remains unclear whether the CD34-positive and CD45-negative cell can differentiate into an adipocyte in denervated muscle.
Two adipogenic transcriptional factors, C/EBP
and/or PPAR
, have been implicated in the co-ordinated activation of adipocyte-specific genes (Gregoire et al. 1998). C/EBP
functions as a trans-activator of aP2 gene promoter (Christy et al. 1989). Similarly, PPAR
2 forms a heterodimeric complex with retinoid X receptor
(RXR
), which can bind to and activate the aP2 enhancer (Tontonoz et al. 1994). We observed that C/EBP
and PPAR
2 were upregulated in denervated muscle, suggesting that increased expression of adipogenic transcriptional factors potentially contribute to FABP4 gene expression. The expression of FABP4 was reduced at 510 days and returned to control levels 30 days after muscle denervation concomitant with increased expression of C/EBP
and PPAR
2. Therefore, it is possible that it takes a longer time to accumulate FABP mRNA after C/EBP
and PPAR
2 are activated in denervated muscle. Intriguingly, when myoblasts from adult mice are cultured under adipocyte-inducing medium, C/EBP
and PPAR
2 mRNAs accumulate but aP2 mRNA does not (Taylor-Jones et al. 2002), suggesting that the activities of transcriptional factors can be regulated post-transcriptionally. For example, mitogen-activated protein kinase-mediated phosphorylation of PPAR
(Hu et al. 1996) and RXR
(Solomon et al. 1999) reduces their activities, while protein kinase A-mediated phosphorylation of PPAR
enhances its activity (Lazennec et al. 2000). Furthermore, aP2 mRNA accumulates in cultured myoblasts from aged mice concomitant with decreased expression of Wnt10b mRNA (Taylor-Jones et al. 2002), suggesting that Wnt10b may play a role in expression of aP2, probably through C/EBP
and PPAR
2. Therefore, further studies are necessary to clarify the role of these transcriptional factors in fatty degeneration induced by muscle denervation.
Consistent with a previous study (Vertino et al. 2005), we observed no apparent lipid accumulation in control muscle, suggesting that activation of adipogenic potential may be inhibited under physiological conditions. The lipid accumulation observed in the denervated muscle suggests that adipogenic potential has been activated. Additionally, lipid accumulation was restricted to the superficial region of the gastrocnemius muscle, which is composed of predominantly fast-twitch muscle fibres. This finding is in agreement with a previous study showing that the kinetics of fatty degeneration is different in fast-twitch and slow-twitch muscles, the former being transformed faster and more completely than the latter (Dulor et al. 1998).
The observed lipid accumulation near blood vessels is consistent with the observations in transgenic mice with an overexpressed ADAM12 (Kawaguchi et al. 2002). This suggests the possibility that the adipocytes originate from mesenchymal progenitor/preadipocytes in the perivascular space. However, the origin of the cells that accumulate lipid remains unknown. In our model, myogenic and adipogenic transcriptional factors were upregulated in denervated muscle. This observation leads us to speculate that the number of cells activating both adipogenic and myogenic potentials may be low because C/EBP
and PPAR
2 have been shown to inhibit myogenic differentiation by downregulating the MyoD family genes in myogenic cells (Hu et al. 1995). Although we did not identify the kind of cell that expresses adipogenoic transcriptional factors, we speculated that preadipocytes would proliferate and differentiate into adipocytes in response to muscle denervation. This possibility may be supported by the observation that sympathetic denervation of white adipose tissue induces preadipocyte proliferation and increases the number of adipocytes (Cousin et al. 1993), suggesting that muscle denervation may stimulate preadipocyte proliferation and accelerate adipocyte differentiation. However, we cannot rule out the possibility that satellite cells (Asakura et al. 2001), and a side population of skeletal muscle-derived stem cells (Jackson et al. 1999), could also differentiate into adipocyte-like cells during muscle denervation; their contribution to fatty degeneration is currently unknown.
In conclusion, we have provided the first evidence that two adipogenic transcriptional factors, C/EBP
and PPAR
2, were upregulated in denervated muscle where lipid accumulation was observed. Although the mechanism by which muscle denervation regulates these adipogenic transcriptional factors remains to be identified, these findings may explain, at least in part, why lipids accumulate in denervated muscle.
| References |
|---|
|
|
|---|
Asakura A, Komaki M & Rudnicki M (2001). Muscle satellite cells are multipotential stem cells that exhibit myogenic, osteogenic, and adipogenic differentiation. Differentiation 68, 245253.[CrossRef][Medline]
Banker BQ & Engel AG (2004). Ultrastructural changes in diseased muscle. In Myology, ed. Engel AG & Franzini-Armstrong C, pp. 720721 and 823827. McGraw-Hill, Inc., New York.
Cai D, Frantz JD, Tawa NE Jr, Melendez PA, Oh BC, Lidov HG, Hasselgren PO, Frontera WR, Lee J, Glass DJ & Shoelson SE (2004). IKKbeta/NF-kappaB activation causes severe muscle wasting in mice. Cell 119, 285298.[CrossRef][Medline]
Christy
RJ, Yang
VW, Ntambi
JM, Geiman
DE, Landschulz
WH, Friedman
AD, Nakabeppu
Y, Kelly
TJ
&
Lane
MD (1989). Differentiation-induced gene expression in 3T3-L1 preadipocytes: CCAAT/enhancer binding protein interacts with and activates the promoters of two adipocyte-specific genes. Genes Dev
3, 13231335.
Cousin B, Casteilla L, Lafontan M, Ambid L, Langin D, Berthault MF & Penicaud L (1993). Local sympathetic denervation of white adipose tissue in rats induces preadipocyte proliferation without noticeable changes in metabolism. Endocrinology 133, 22552262.[Abstract]
Cowherd RM, Lyle RE & McGehee RE Jr (1999). Molecular regulation of adipocyte differentiation. Semin Cell Dev Biol 10, 310.[CrossRef][Medline]
Dulor JP, Cambon B, Vigneron P, Reyne Y, Nougues J, Casteilla L & Bacou F (1998). Expression of specific white adipose tissue genes in denervation-induced skeletal muscle fatty degeneration. FEBS Lett 439, 8992.[CrossRef][Medline]
Eftimie
R, Brenner
HR
&
Buonanno
A (1991). Myogenin and MyoD join a family of skeletal muscle genes regulated by electrical activity. Proc Natl Acad Sci
88, 13491353.
Gregoire
FM, Smas
CM
&
Sul
HS (1998). Understanding adipocyte differentiation. Physiol Rev
78, 783809.
Hu
E, Kim
JB, Sarraf
P
&
Spiegelman
BM (1996). Inhibition of adipogenesis through MAP kinase-mediated phosphorylation of PPARgamma. Science
274, 21002103.
Hu
E, Tontonoz
P
&
Spiegelman
BM (1995). Transdifferentiation of myoblasts by the adipogenic transcription factors PPAR gamma and C/EBP alpha. Proc Natl Acad Sci
92, 98569860.
Ishido M, Kami K & Masuhara M (2004). In vivo expression patterns of MyoD, p21, and Rb proteins in myonuclei and satellite cells of denervated rat skeletal muscle. Am J Physiol 287, C484C493.
Jackson
KA, Mi
T
&
Goodell
MA (1999). Hematopoietic potential of stem cells isolated from murine skeletal muscle. Proc Natl Acad Sci
96, 1448214486.
Kawaguchi
N, Xu
X, Tajima
R, Kronqvist
P, Sundberg
C, Loechel
F, Albrechtsen
R
&
Wewer
UM (2002). ADAM 12 protease induces adipogenesis in transgenic mice. Am J Pathol
160, 18951903.
Koopman R, Schaart G & Hesselink MK (2001). Optimisation of oil red O staining permits combination with immunofluorescence and automated quantification of lipids. Histochem Cell Biol 116, 6368.[Medline]
Lazennec
G, Canaple
L, Saugy
D
&
Wahli
W (2000). Activation of peroxisome proliferator-activated receptors (PPARs) by their ligands and protein kinase A activators. Mol Endocrinol
14, 19621975.
Mandrup
S
&
Lane
MD (1997). Regulating adipogenesis. J Biol Chem
272, 53675370.
Morrison RF & Farmer SR (1999). Insights into the transcriptional control of adipocyte differentiation. J Cell Biochem Suppl 3233, 5967.[CrossRef]
Rosen ED (2005). The transcriptional basis of adipocyte development. Prostaglandins Leukot Essent Fatty Acids 73, 3134.[CrossRef][Medline]
Rosen
ED, Hsu
CH, Wang
X, Sakai
S, Freeman
MW, Gonzalez
FJ
&
Spiegelman
BM (2002). C/EBPalpha induces adipogenesis through PPARgamma: a unified pathway. Genes Dev
16, 2226.
Ross
SE, Hemati
N, Longo
KA, Bennett
CN, Lucas
PC, Erickson
RL
&
MacDougald
OA (2000). Inhibition of adipogenesis by Wnt signaling. Science
289, 950953.
Solomon C, White JH & Kremer R (1999). Mitogen-activated protein kinase inhibits 1,25-dihydroxyvitamin D3-dependent signal transduction by phosphorylating human retinoid X receptor alpha. J Clin Invest 103, 17291735.[Medline]
Tamaki
T, Akatsuka
A, Ando
K, Nakamura
Y, Matsuzawa
H, Hotta
T, Roy
RR
&
Edgerton
VR (2002). Identification of myogenic-endothelial progenitor cells in the interstitial spaces of skeletal muscle. J Cell Biol
157, 571577.
Tanabe
Y, Koga
M, Saito
M, Matsunaga
Y
&
Nakayama
K (2004). Inhibition of adipocyte differentiation by mechanical stretching through ERK-mediated downregulation of PPARgamma2. J Cell Sci
117, 36053614.
Taylor-Jones JM, McGehee RE, Rando TA, Lecka-Czernik B, Lipschitz DA & Peterson CA (2002). Activation of an adipogenic program in adult myoblasts with age. Mech Ageing Dev 123, 649661.[CrossRef][Medline]
Tontonoz
P, Graves
RA, Budavari
AI, Erdjument-Bromage
H, Lui
M, Hu
E, Tempst
P
&
Spiegelman
BM (1994). Adipocyte-specific transcription factor ARF6 is a heterodimeric complex of two nuclear hormone receptors, PPAR gamma and RXR alpha. Nucl Acids Res
22, 56285634.
Vertino
AM, Taylor-Jones
JM, Longo
KA, Bearden
ED, Lane
TF, McGehee
RE
Jr, MacDougald
OA
&
Peterson
CA (2005). Wnt10b deficiency promotes coexpression of myogenic and adipogenic programs in myoblasts. Mol Biol Cell
16, 20392048.
Vidal-Puig A, Jimenez-Linan M, Lowell BB, Hamann A, Hu E, Spiegelman B, Flier JS & Moller DE (1996). Regulation of PPAR gamma gene expression by nutrition and obesity in rodents. J Clin Invest 97, 25532561.[Medline]
Warren
GL, Hulderman
T, Jensen
N, McKinstry
M, Mishra
M, Luster
MI
&
Simeonova
PP (2002). Physiological role of tumor necrosis factor alpha in traumatic muscle injury. FASEB J
16, 16301632.
Zhu
Y, Qi
C, Korenberg
JR, Chen
XN, Noya
D, Rao
MS
&
Reddy
JK (1995). Structural organization of mouse peroxisome proliferator-activated receptor gamma (mPPAR gamma) gene: alternative promoter use and different splicing yield two mPPAR gamma isoforms. Proc Natl Acad Sci
92, 79217925.
| Acknowledgements |
|---|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |